Overall, 105 were found to suffer from a FSD. Patients were evaluated on two subsequent visits to validate the abridged form of the questionnaire. Forty women were excluded because they had no sexual activity or failed to attend the retest visit. We interviewed and administered the FSFI-19 to 200 women attending outpatient clinics for sexual and reproductive medicine. The purpose of this study was to prepare and validate an abridged form of the most popular psychometric diagnostic test (Female Sexual Function Index, FSFI-19) to provide a fast screener of FSD for easy use in outpatient visits, epidemiological studies, and assessment of treatment response. Often, practitioners avoid investigating sexual symptoms due to concerns of insufficient time or lack of proper tools to address FSD. A limiting step in the evaluation of female sexual dysfunction (FSD) is the availability of a rapid screening procedure.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |